Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Mangoceuticals, Inc.
Company profile

Mangoceuticals, Inc.

NASDAQ: MGRX · Healthcare · Medical - Healthcare Information Services
PublicHQ Dallas, TX · DallasCIK 0001938046Reports USD
#931 of 1,394 Healthcare companies by revenuebottom-quartile growth
EA Score
29D
FH 34DQ 19GM 42SS 19
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, 3-yr revenue growth · ↓ growth stability, listing tenure
Methodology →
Revenue TTM
$414.6k
Rev growth YoY (TTM)
-18.9%
Net income (FY)
-$20.6M
Employees
3
Market cap
$4.8M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$456.0k$456.0k2025
Net income-$20.6M-$20.6M2025
Operating income-$18.0M-$18.0M2025
Total assets$16.1M$16.1M2025
Liabilities$890.6k$890.6k2025
Equity$15.2M$15.2M2025

Revenue trend

FY2023 – FY2025 · USD
$8.9k
FY23
$731.5k
FY23
$615.9k
FY24
$456.0k
FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Mangoceuticals, Inc. booked $456.0k in FY2025 revenue, contracting 26% year over year — slower than 75% of Healthcare companies we track, at a -4526.8% net margin.

Peers · Healthcare
Xcelerate Inc.——Quince Therapeutics, Inc.——Christina Lake Cannabis Corp.64CAprea Therapeutics, Inc.——
Neighbors
Dallas →
Caterpillar Inc.$67.6B80B+Texas Instruments Incorporated$17.7B86AAT&T Inc.$125.6B82B+McKesson Corporation$403.4B85AStrive, Inc. Variable Rate Series A Perpetual Preferred Stock$1.5M28DEnergy Transfer LP$85.5B70B
Key facts
CEOJacob D. Cohen
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersDallas, TX
ExchangeNASDAQ: MGRX
Employees3
IPO date2023-03-21
Latest filings
8-K2026-07-0210-Q2026-05-1910-K2026-04-018-K2026-03-178-K2026-02-238-K2026-02-198-K2026-02-068-K2025-12-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies